Keyphrases
Tumor Necrosis Factor-α
100%
Inflammatory Bowel Disease
100%
Mucosal Injury
100%
Inhibitory Activity
100%
Synbiotics
100%
Jejunoileal
100%
MRNA Expression
40%
Methotrexate
40%
Experimental Colitis
40%
Adverse Effects
20%
Maintenance Therapy
20%
Goblet Cells
20%
Macrophages
20%
Novel Therapeutics
20%
Intestine
20%
Reducing Activity
20%
Myeloperoxidase
20%
Superoxide Dismutase Activity
20%
Villi
20%
Protective Behavior
20%
Mucosa
20%
Mucositis
20%
Chemically Induced
20%
Intestinal Permeability
20%
Crohn's Disease
20%
Interleukin-12 (IL-12)
20%
Gastroenteritis
20%
Cell Depletion
20%
Intestinal Function
20%
Biological Modifier
20%
Crypt
20%
Intestinal Integrity
20%
Lipid Peroxidase
20%
VSL#3
20%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Injury
100%
Tablet
100%
Synbiotic Agent
100%
Inflammatory Bowel Disease
71%
Methotrexate
28%
Experimental Colitis
28%
Superoxide Dismutase
14%
Adverse Event
14%
Myeloperoxidase
14%
Mucosa Inflammation
14%
Interleukin 12
14%
Crohn's Disease
14%
Intestinal Permeability
14%
Enterocolitis
14%
Lipid Peroxidase
14%
VSL3
14%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Inflammatory Bowel Disease
100%
Synbiotics
100%
Colitis
40%
Methotrexate
40%
Superoxide
20%
Goblet Cell
20%
Macrophage
20%
Animal Experiment
20%
Crohn's Disease
20%
Intestine
20%
Mucosa
20%
Interleukin 12
20%
Enterocolitis
20%
Intestine Function
20%